NRG-LU008

Lung Cancer

Phase III Prospective Randomized Trial Of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed By Concurrent Mediastinal Chemoradiation For Locally Advanced Non-Small Cell Lung Cancer

Key Team Members

Principal Investigator

Quillin Davis, MD

Research Coordinator

Selena Lollar

Accepting Patients

Enrollment Started: July 29, 2024

Check if You’re Eligible

(803) 935-8300

Research@lexhealth.org

About the Trial

NRG-LU008 is a clinical study for people with non-small cell lung cancer (NSCLC) that has spread to lymph nodes in the chest and is not able to be treated by surgery.